Pulmonary superoxide dismutase (SOD) plays an important role in the lung defense against 0 2 toxicity. We have previously demonstrated that tracheal huf€lation of interleukinla (IL-1) selectively enhance pulmonary MnSOD and protects rats against 0 2 toxicity. However, little is known about the cellular distribution of pulmonary MnSODand CuZnSOD-specific proteins. We performed immunohistochemistry in plastic sections (2 pm thick) to determine the e&cts of hyperoxia and IL1 on the cellular distribution of pulmonary MnSOD and CuZnSOD in rats. MnSOD and CuZnSOD were present in all lung &. Smooth musde and endothelial cells appeared to contain higher immunoreactive MnSOD and CuZnSOD proteins than other lung a l l types. Exposute of rats to 100% 0 2 for 24 hr had no e l k t
Introduction
The superoxide dismutases (SODS) are a family of metalloenzymes that catalyze the dismutation o f 0 2 -to H 2 0 2 and 0 2 . Three forms of SOD, with distinct distribution and characterized by their metal components, exist inmammalian lungs: CuZnSOD, MnSOD, and ECSOD (extracellular SOD) (9, 11) . Intracellular CuZnSOD constitutes approximately 85-90% of the total cellular SOD activity. MnSOD, which constitutes 10-15% of the total cellular SOD activity, is strategically located in mitochondria, a major site of 0 2production under hyperoxic conditions (8) . ECSOD is a CuZncontaining enzyme immunologically distinct from the intracellular CuZnSOD. It is the dominant SOD isozyme in the plasma. Hawever, its tissue content is much lower than that of CuZnSOD or MnSOD. In rat lung, ECSOD constitutes <5% of the total CuZn-,containing SOD activity (11).
Considerable evidence supports the importance of intracellu- on the cellular distribution and intensity of pulmonary MnSOD. However, at 50 hr &er 0 2 exposure the intensity of pulmonary MnSOD was reduced. In contnst, tracheal in-&tion of IL1 markedly enhanced the intensity of pulmonary MnSOD in rats exposed to 0 2 for 50 hr. Neither 0 2 arponuc nor IL1 imuHation had any apparent c&ct on the distribution and intensity of pulmonary CuZnSOD. We condude that IL1 lar CuZnSOD and mitochondria MnSOD in the pulmonary defense against 0 2 toxicity (16). However, little is known about the cellular distribution of pulmonary CuZnSOD-and MnSOD-specific proteins, and their relationship to the cellular resistance to hyperoxia. Previous immunohistochemical studies (4, 7, 12, 15) in rats revealed MnSOD and CuZnSOD proteins in bronchiolar epithelial cells, alveolar cells, and mesothelium (little or none in endothelial cells). Ultrastructural and morphometric studies (2,5) have suggested that in rats, endothelial cells are the primary target of pulmonary 0 2 toxicity. Whether this is related to the endothelial content of SOD is not clear.
We have previously demonstrated that exposure of rats to 100% 0 2 results in m30% reduction in levels of pulmonary MnSOD protein and enzyme activity at 2.3 days after 0 2 exposure, by which time rats start to die of 0 2 toxicity (17, 19) . In contrast, tracheal insufflation of tumor necrosis factor ("F) or interleukin-1 (IL1) selectively enhances pulmonary MnSOD protein and enzyme activity at 2.3 days after 0 2 exposure, and markedly prolongs the survival of rats exposed to 100% 0 2 (17) (18) (19) (20) . Since measurements of MnSOD protein and enzyme activity are performed with lung extracts, it is not clear whether changes in MnSOD protein and enzyme activity are manifested in all lung parenchymal cells or only in selective lung cell types. In the present study we determined the cellular distribution of pulmonary MnSOD and CuZnSOD in rats by immunohistochemistry and the effect of hyperoxia and IL1.
Materials and Methods
Materials. The following materials were purchased commercially: glycol methacrylate from Polysciences (Warrington, PA); trypsin from Shandon-Lipshaw (Detroit, MI); biotinylated anti-rabbit and anti-goat IgG antibodies and alkaline phosphatase-labeled avidin from Biogenix (San Ramon, CA); Fast Red (diazonium salt) chromogen from Biomedia (Foster City, CA). Rabbit anti-human MnSOD antibody, which crossreacts with rat MnSOD (18, 20) , was obtained from Dr. Larry Oberley (University of Iowa, Ames, IA) and monospecific goat anti-rat CuZnSOD antibody was kindly provided by Dr. Donald Massaro (Georgetown University; Washington, DC). We have previously shown that immunoblots of rat lung homogenates using these MnSOD or CuZnSOD antibodies reveal a single band with molecular weight corresponding to rat MnSOD or CuZnSOD, respectively (18, 20) . Ttacheal Insufflation of IG1 and Exposure of Rats to 0 2 : These procedures were performed as described previously (19). Briefly, male Sprague-Dawley rats (Harlan Sprague-Dawley; Altamont, NY), free of respiratory infections and weighing 250-350 g, were anesthetized with methoxyflurane (Pitman-Moore; Washington Crossing, NJ) and intubated with a 16-gauge IV catheter (Angiocath Becton-Dickinson, Sandy, UT). One ml of calcium-magnesium-free Hanks' balanced salt solution (HBSS) containing 5 pg IL1, or 1 ml HBSS for control animals, followed by 2 ml of air, was injected into the lungs through the intratracheal catheter. Auscultation of the chest was performed with a stethoscope to ensure that solution was insufflated into the lungs.
After rats had recovered from the effect of anesthesia they were placed in a lucite chamber. The concentration of 0 2 in the chamber was maintained at > 99% at all times. The animals were given free access to water and diet. Control exposure (normoxia) was performed in room air.
Tissue Preparation for ImmunohistochemisUy. Preliminary experiments established the following optimal procedures for fixation of lung tissue and preservation of antigenicity for immunohistochemical localization of MnSOD and CuZnSOD. At 24 hr after normoxic exposure and at 24 or 50 hr after hyperoxic exposure, rats were anesthetized with IP pentobarbital sodium and exsanguinated. Lungs were fixed in situ by intratracheal instillation of 5 ml ice-cold modified McClean's solution (0.1 M lysine, 0.1 M phosphate buffer, pH 7.4, 1% formaldehyde, 0.5% ZnC12) for 20 min. Tissue specimens (approximately 5 x 5 x 1 "3) from each lung were taken and placed in fresh modified McClean's solution for 4 hr at 4°C. The specimens were then placed in a microwave oven for 3 min at 55'C (final temperature achieved) and further processed at 4'C according to Berkstead (1). Briefly, after washing with 0.05 M N&CI, specimens were dehydrated in a graded series of acetone and infiltrated with glycol methacrylate. They were embedded in a mixture of glycol methacrylate (20 ml, without catalyst), benzoperoxide (0.45 %), and polyethylene glycol with N,N-dimethylaniline (0.5 ml) (Polysciences), and were allowed to polymerize overnight at 4'C. Consecutive sections were cut at 2 pm thickness to obtain single cell-thickness sections for better resolution and greater structural detail (21) , mounted, and allowed to dry overnight at room temperature (RT).
Immunohistochemistry. This was performed according to Beckstead (1) . Tissue sections were trypsinized (trypsin 1 mg/ml, 0.1% CaC12 in 0.05 M Tris buffer, pH 7.4) for 15 min at 37°C. After washing, they were placed in 0.05 M Tris-buffered saline containing Brij-30, pH 7.6 (Biomedia) and blocked with 0.1% casein for 10 min at 37'C. Sections were then incubated with primary antibodies (rabbit anti-human MnSOD, 1:200 dilution or goat anti-rat CuZnSOD, 1:SOOO) for 1 hr at RT, followed by biotinylated secondary antibodies (goat anti-rabbit IgG 1:50 for MnSOD or horse antigoat IgG 1:lOO for CuZnSOD) for 30 min at 37°C and alkaline phosphataselabeled streptavidin (1:SO) for 1 hr at 37". The alkaline phosphatase activity was developed with diazonium salt (Fast Red chromogen) for 15 min at RT and the slides were counterstained with hematoxylin, rinsed, air-dried. and mounted with water-soluble crystal mount for light microscopic examination.
Negative controls for immunostaining were performed by replacing the primary antibodies with normal rabbit (for MnSOD) or goat (for CuZn-SOD) serum at similar dilutions as the primary antibodies. Additional controls were performed with anti-MnSOD (1:200 dilution) and anti-CuZnSOD (1:SOOO dilution) antibodies that had been absorbed with purified MnSOD (300 pglml) and CuZnSOD (200 pglml), respectively, to confirm the specificity of immunostaining. Lung tissue sections from control and experimental groups were immunostained identically at the same time to allow semiquantiative comparison among various groups. At least two or three experiments were performed in each group to ensure accurate and reproducible results.
Immunohistochemical Localization of Pulmonary

CuZnSOD in Normal Rats
Lungs of rats exposed to normoxia showed generalized immunostaining with anti-CuZnSOD antibody (Figures 1B-ID) compared with negative staining using control serum ( Figure 1A) . Smooth muscle and endothelial cells of small arteries exhibited moderate CuZnSOD immunoreactivity ( Figure 1B) . Epithelial cells of bronchioles displayed patchy staining, with non-ciliated cells stained much more intensely than the ciliated cells ( Figure IC) . Alveolar septa were lightly stained ( Figures 1B-1D ). The specificity of CuZn-SOD immunostaining was further confirmed by using anti-CuZnSOD antibody that had been absorbed with purified CuZn-SOD, which produced results similar to Figure 1A .
Immunohistochemical Localization of PuZmonary
MnSOD in Normal Rats
Pulmonary MnSOD also showed diffuse distribution (Figure 2) . Compared with negative staining using control serum (not shown but similar to Figure IA) , endothelial cells and smooth muscle of small arteries (Figure 2A ) and endothelial cells of arterioles (Figure 2B) showed moderate MnSOD staining. The bronchioles showed light but relatively uniform staining of all epithelial cells, although non-ciliated cells stained slightly more heavily than ciliated cells. Bronchiolar smooth muscle exhibited pronounced staining (Figure 2C) . Alveolar septa and pleura also showed light MnSOD Immunoreactivity ( Figure 2D ). Absorption of anti-MnSOD antibody with purified MnSOD completely abolished the immunostaining (data not shown), confirming the specificity of MnSOD immunostaining. 
Efect of Hypemd and LGl
The distribution and intensity of pulmonary MnSOD i"unomftivity in rats insufflated with HBSS (control) or ILI and exposed to 100% 0 2 for 24 hr were similar to those of normoxia-exposed controls (data not shown). In contrast, at 50 hr after 0 2 exposure the intensity of pulmonary MnSOD immunoreactivity was uniformly reduced in control rats ( Figures 3A and 3B) , whereas it was markedly increased in IL1-02-ueated animals (Figures 3C and 3D) . Compared with normoxic controls (Figure 2) , MnSOD staining of endothelial cells and smooth muscle of small arteries (Figure 3A) and endothelial cells of pre-capillary arterioles and alveolar septa (Figurcs 3B) of 02-exposed conuols was decreased. In contrast. in IL1-02-ueated rats, MnSOD immunoreactivity was markedly i n d in smooth m d e and endothelial cells ofsmall arteries and pre-capillary arterioles (Figures 3C and 3D) . Smaller increases were noted in alveolar septa and bronchiolar epithelial cells (data not shown).
Compared with normoxia-exposed controls ( Figure 2) . there was no difkrencc in the distribution and intensity of pulmonary CuZn-SOD immunoreactivity in rats insufflated with HBSS (control) or ILl and exposed to 100% 0 2 for 24 or 50 hr (data not shown).
Discussion
In this study, using immunohistochemical methods, we demonstrated that MnSOD and CuZnSOD were present in practically all cells of rat lung. Smooth muscle and endothelial cells appeared to contain higher amounts of immunoreactive MnSOD and CuZn-SODpmteins thanotherlungccll typcs. ~o f r a t s t o 100% 02 for 24 hr had no &ect on the cellular distribution and intensity (concentration) of pulmonary MnSOD. Howcvcr, at 50 hr after 0 2 exposure the intensity of pulmonary MnSOD was reduced. In contrast, tracheal insufZlation ofIL1 markedly enhanced the intensity of pulmonary MnSOD in rats exposed to 0 2 for 50 hr. Neither 0 2 exposurc nor ILl iasufflation had any apparent &ect on the distribution and intensity of pulmonary CuZnSOD. These results are consistent with previous observations of the effects of 0 2 and IG1 using enzymatic assays and immunoblot analyses of rat lung homogenatcs (17) (18) (19) (20) .
Proper tissue fmtion and preservation of antigenicity an essential for the immunohistochemical localization of pulmonary MnSOD and CuZnSOD. Frozen section appears to preserve the antigenicity but docs not preserve lung architecture, since lung is a collapsible organ. Formalin fmtion and p d i embedding preserve lung architecture but may destroy SOD antigenicity. Using various combinations of formalin fmtion and p d i embedding. a number of studies have shown the predominant presence of MnSOD and CuZnSOD in bronchial epithelium in rat (4.7.12, 15), harnster (14) , mouse (13). and human lungs (12) . Few o f t h a studies mention the presence of MnSOD or CuZnSOD in the endothelium.
In a recent study, Cousin et al. (4) demonstrated that formalin fmtion desuoyed MnSOD and CuZnSOD antigenicity in rat lungs, resulting in no immunostaining of these two enzymes. However, zinc-formalin (10% unbuffered formalin with 1% zinc sulfate) fixation resulted in immunostaining of pulmonary MnSOD, whereas CuZnSOD remained unstainable. In the same study, using Carson-Millonig's fixative (4% formaldehyde in 0.16 M monobasic sodium phosphate, pH 7.2), MnSOD and CuZnSOD were detected in all lung cells by immunogold electron microscopy (4).
We have also found that formalin fixation destroys pulmonary MnSOD and CuZnSOD antigenicity, whereas fixation with modified McClean's solution and plastic embedding (glycol methacrylate) provide good preservation of both lung architecture and antigenicity of MnSOD and CuZnSOD. The cellular distribution of these two enzymes in the lung is similar to that observed by immunogold electron microscopy as described by Coursin et al. (4) .
of particular interest was the prominent immunostaining of smooth muscle and endothelial cells for MnSOD and CuZnSOD. Some bronchiolar epithelial cells were stained more intensely than others for CuZnSOD. However, without immunogold electron microscopy we were unable to determine with certainty whether ciliated or nonciliated bronchiolar epithelial cells contained more CuZnSOD.
Prolonged exposure to a sublethal dose of 0 2 (e.g., 85% 0 2 ) for 5-7 days results in enhanced pulmonary antioxidant enzymes, including MnSOD and CuZnSOD, leading to resistance to subsequent exposure to a lethal dose of 0 2 (>95% 0 2 ) (6,lO). In contrast, exposure of normal rats to a lethal dose of 0 2 for about 2 days results in reduced pulmonary MnSOD and the animals start to die of 0 2 toxicity shortly thereafter (17,lg) . No immunohistochemical study of pulmonary MnSOD and CuZnSOD has been reported for rats exposed to a sublethal dose of Oz. However, a recent study by Clyde et al. (3) using in situ hybridization reveals that in rats exposed to air or 85% 0 2 for 3 days MnSOD mRNA is present in arterioles, septal tips of alveolar ducts, alveolar Type 11 epithelial cells, and mesothelial cells. In addition, hypetoxic (85 % 0 2 ) lung has an intense, continuous labeling of the pleura that is distinctly greater than the intermittent labeling of the pleura in control, air-exposed rats. It is not clear whether this increase in MnSOD mRNA is due to the direct effect of sublethal 0 2 (85%) or the effect of IL1 or TNF, which might be produced as a result of sublethal 0 2 exposure. In the present study, we demonstrated that exposure to 100% 0 2 for 50 hr selectively reduced pulmonary MnSOD, but not CuZnSOD, in all lung cells.
We have previously demonstrated that tracheal insdation but not IP injection of TNF or IL1 selectively enhances pulmonary MnSOD and markedly prolongs the survival of rats exposed to 100% 0 2 (17J9). It was not clear whether the increased pulmonary MnSOD caused by cytokine insufflation was manifested in all lung parenchymal cells or was present only in selective lung cell types.
Recently, Wispe et al. (22) reported that transgenic expression of human MnSOD mRNA leading to an increased MnSOD protein in mitochondria of mouse Type 11 alveolar and non-ciliated bronchiolar epithelial cells conferred protection against 0 2 toxicity. These results suggest that enhancement of pulmonary MnSOD in alveolar and bronchiolar epithelial cells is sufficient to protect animals against 0 2 toxicity. In the present study we demonstrated that tracheal insufflation of IL1 selectively enhanced pulmonary MnSOD but not CuZnSOD, and that this enhancement was manifested in most lung cells, particularly smooth muscle and endothelial cells.
